fenofibrate (Triglide) - Product Profile

BioCentury | Jan 8, 2019

Distillery Therapeutics

Cancer

...TriLipix fenofibric acid for dyslipidemia. Vectura Group plc and Shionogi & Co. Ltd. market Triglide fenofibrate...

BioCentury | Jun 15, 2015

Company News

Sun Pharmaceutical, Tribute Pharmaceuticals deal

Tribute purchased U.S. rights from Sun to Fibricor fenofibric acid and its related authorized generic. Sun receives $5 million upon closing of the deal, plus $2 million six months after closing and $3 million 12...

BioCentury | Jan 15, 2015

Distillery Therapeutics

Therapeutics: Peroxisome proliferator activated receptor (PPAR) α; PPARγ coactivator 1-α (PPARGC1A, PGC-1a)

...a mouse model of folic acid-induced kidney fibrosis, transgenic overexpression of PPARGC1A or treatment with fenofibrate...

BioCentury | Jan 12, 2015

Emerging Company Profile

Targeting transcription regulators

...of Inventiva's medicinal chemistry and biology staff is from the Fournier group that discovered the fenofibrate...

BioCentury | Nov 24, 2014

Product Development

LDL Does IMPROVE IT

...University School of Medicine. Two other agents whose lipid-modifying properties included LDL-lowering - niacin and fenofibrate...

BioCentury | Apr 14, 2014

Product Development

Family resemblance

...have a relatively low LDL, I can probably get by taking ezetimibe and maybe a fenofibrate...

BioCentury | Feb 3, 2014

Regulation

Lipid advice in Europe

...considering 2010 data from the Phase III ACCORD Lipid CV outcomes trial, which showed TriCor fenofibrate...

BioCentury | Feb 3, 2014

Finance

Quick payday on single cell sale

...autoimmune drug Humira adalimumab were up 13% to $3B, while sales of cholesterol drugs TriCor fenofibrate...

BioCentury | Nov 4, 2013

Clinical News

Antara fenofibrate regulatory update

...Lupin said FDA approved an sNDA for 30 and 90 mg strengths of Antara fenofibrate as...
...Ethypharm. Ethypharm S.A. , St. Cloud, France Lupin Ltd. (NSE:LUPIN; BSE:500257), Mumbai, India Product: Antara fenofibrate...

BioCentury | Oct 28, 2013

Finance

Paying the iron price

...autoimmune drug Humira adalimumab were up 16% to $2.8B, while sales of cholesterol drugs TriCor fenofibrate...